When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Progyny just met that criteria with a new score of 81.
IBD's unique rating identifies share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners tend to have an RS Rating of over 80 as they begin their biggest runs.
Risk Management In The Stock Market: How Much Money To Invest Now
While now is not an ideal time to jump in, see if the stock is able to form a consolidation and break out.
The company showed 5% earnings growth in the latest quarterly report, while sales growth came in at 2%. Keep an eye out for the company's next round of numbers on or around Feb. 27.
The company holds the No. 5 rank among its peers in the Medical-Services industry group. Hims & Hers Health is the No. 1-ranked stock within the group.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
